Use access key #2 to skip to page content.
$48.38 0.83 (1.75%)
8/21/2008 4:01 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

0

Avatar manchesteruk (< 20) Submitted: 10/05/06 3:23 AM : Outperform Start Price: $58.20 AZN Score: -11.61

strong existing brands. but can they be replaced?

Report this Post Replies: 1 | Reply

Avatar lsxwcm (< 20) Submitted: 11/07/06 2:21 PM

Recs: 0 | Rec This

Exactly, which is why I am selling.

Report this Post Reply

Featured Broker Partners